Japan

Japan’s PMDA issues GMP Certificate to Lupin’s Mandideep facility

Read more

Japan drug price reforms risk hurting investment: Bristol-Myers CEO

Read more

Sun Pharma Announces Regulatory Filing of Tildrakizumab in Japan

Read more

Sun Pharma enters Japanese prescription market

Read more

Lupin’s subsidiary to set up plant in Japan

Read more

Japan’s Daiichi Sankyo sells Sun Pharma stake

Read more